-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Bladder cancer is the most common malignant tumor in the urinary system, accounting for 90%-95% of urothelial cancers
Bladder cancer is the most common malignant tumor in the urinary system, accounting for 90%-95% of urothelial cancers
Previous studies have shown that patients with non-muscle invasive bladder cancer have a higher survival rate, with a 5-year progression-free survival rate of 93% in the low-risk group and 54% even in the high-risk group
SBSN (Suprabasin), a gene expressed in mouse and human differentiated keratinocytes, is a marker of epidermal differentiation and a potential precursor of the keratinized envelope
SBSN enhanced the phosphorylation levels of EGFR and SRC kinases, which subsequently affected the phosphorylation and nuclear localization status of STAT3
Zhou, Z.
https://doi.
org/10.
1038/s41416-022-01794-7.
Leave a comment here